Document Detail

Ventricular Assist Devices (VAD) Therapy: New Technology, New Hope?
MedLine Citation:
PMID:  23519193     Owner:  NLM     Status:  In-Data-Review    
Ventricular assist devices are commonly utilized in the treatment of end-stage heart failure. Advances in continuous flow technology have improved efficiency, size, implantability, extended support, and overall patient outcomes. This has led to an expanded role of left ventricular assist device (LVAD) clinical use and applications. This review describes the advances and current state of LVAD devices and provides a future outlook for this technology.
Limael E Rodriguez; Erik E Suarez; Matthias Loebe; Brian A Bruckner
Related Documents :
12078773 - Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis.
1084663 - Thrombotic obstruction of bjork-shiley tricuspid valve prosthesis. report of three case...
22981263 - Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocar...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Methodist DeBakey cardiovascular journal     Volume:  9     ISSN:  1947-6108     ISO Abbreviation:  Methodist Debakey Cardiovasc J     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-03-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101508600     Medline TA:  Methodist Debakey Cardiovasc J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  32-7     Citation Subset:  IM    
Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acetate adaptation of clostridia tyrobutyricum for improved fermentation production of butyrate.
Next Document:  A silver(i)-catalyzed tandem reaction of 2-alkynylbenzaldoximes with ketenes.